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Background: Medication adherence is crucial for positive outcomes in the management of 
chronic conditions. Comprehensive medication consultation can improve medication adherence 
by addressing intentional and unintentional nonadherence. The Medicare Part D prescription 
drug benefit has eliminated some cost barriers. We sought to examine variables that impact 
self-reported medication adherence behaviors in an ambulatory Medicare-beneficiary popula-
tion and to identify the factors that influence what information is provided during a pharmacist 
consultation.
Methods: Medicare beneficiaries who attended health fairs in northern California were offered 
medication therapy management (MTM) services during which demographic, social, and health 
information, and responses to survey questions regarding adherence were collected. Benefi-
ciaries were also asked which critical elements of a consultation were typically provided by 
their community pharmacist. Survey responses were examined as a function of demographic, 
socioeconomic, and health-related factors. 
Results: Of the 586 beneficiaries who were provided MTM services, 575 (98%) completed the 
adherence questions. Of responders, 406 (70%) reported taking medications “all of the time”. Of the 
remaining 169 (30%), the following reasons for nonadherence were provided: 123 (73%) forgetful-
ness; 18 (11%) side effects; and 17 (10%) the medication was not needed. Lower adherence rates 
were associated with difficulty paying for medication, presence of a medication-related problem, 
and certain symptomatic chronic conditions. Of the 532 who completed survey questions regarding 
the content of a typical pharmacist consultation, the topics included: 378 (71%) medication name 
and indication; 361 (68%) administration instructions; 307 (58%) side effects; 257 (48%) missed-
dose instructions; and 245 (46%) interactions.  Subsidy recipients and non-English speakers were 
significantly less likely to be counseled on drug name, indication, and side effects. The presence 
of certain health conditions was also associated with missing consultation elements.
Conclusion: While Medicare beneficiaries are generally adherent to medication therapy, 
adherence barriers must be identified and addressed during comprehensive medication 
consultation.
Keywords: pharmacist consultation, adherence behaviors
Background
In 2003, the World Health Organization produced a report entitled “Adherence to 
Long-Term Therapies: Evidence for Action”, in which the average adherence rate 
to therapies for chronic conditions in developed countries was a sobering 50%.1 The 
report emphasized that the cause of poor adherence does not reside with the patient 
but rather, with the health system. It identified the importance of a health care team 
that includes the patient and that has training in adherence strategies. The report also 
called for additional assessments, not only of adherence rates, but also, of the fac-
tors that impact it. Adherence rates in the Medicare population have already been 
examined. In 2013, a report was published regarding medication adherence in all 
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50 States. In addition to other adherence measures, medica-
tion possession ratios, defined as the ratio of the total days 
the member had drug available to the number of possible 
days the member could have drug on hand, were reported.2 
The report provided a state-wide average, adjusted for age 
and sex. The results provide a comparison of adherence rates 
in three distinct market segments: Medicare Part D (MPD) 
beneficiaries, employer health plan holders, and personal 
health plan holders. Adherence rates were highest in the 
MPD population. 
Poor adherence increases the risk of morbidity, hospitaliza-
tion, and mortality, thus has clear implications for worsening 
health outcomes as well as increasing health care costs.3 In four 
common conditions – hypertension, diabetes, hyperlipidemia, 
and heart failure – higher levels of medication adherence have 
been found to be associated with lower hospitalization rates.4 
Medication nonadherence has been estimated to cost the health 
care system approximately $100 billion in hospitalizations 
annually and $2,000 per patient year in excess physician visits.5 
An estimate of excess health care costs in the United States due 
to medication nonadherence approaches $290 billion annual-
ly.6 In a review of the predictors of adherence, Touchette and 
Shapiro reported that lower adherence rates are associated with 
increased complexity of the drug regimen and other factors, 
including number of medications, poor patient–provider rela-
tionship, lower socioeconomic status, poor prescription drug 
coverage, presence of medication side effects, living alone, 
and treatment of asymptomatic conditions and specific health 
conditions, such as depression and cognitive impairment.7 
Other risk factors associated with poor adherence include 
confusion or forgetfulness, language barriers, and “feeling 
well enough to forgo taking the medication”.6 Medication cost, 
including copayments, contributes to medication nonadher-
ence in uninsured, elderly, indigent, and homeless populations, 
but also, in middle-income patients with prescription coverage 
and Medicare recipients.8–11 
In 2006, the MPD benefit was introduced to help ben-
eficiaries pay for their outpatient prescription medications. 
However, with the advent of MPD, may have come com-
placency with respect to the identification and resolution of 
cost-related barriers to medication adherence. Beneficiaries 
of MPD may still have difficulty with their medication costs 
and may therefore benefit from additional governmental 
assistance, either Medicaid or the Low-Income Subsidy. In 
this manuscript, subsidy recipients refers to those beneficia-
ries who had either Medicaid or the Low-Income Subsidy. 
While MPD removed many cost related barriers to medica-
tion adherence, it also created one for beneficiaries who enter 
the coverage gap known as the “Donut Hole” – during this 
time, many patients become nonadherent to their medication 
 therapy, as they are unable to pay for their share of prescrip-
tion costs.12 In 2013, there were over 50 million Medicare ben-
eficiaries, and this number is projected to grow to 72 million 
by 2030.13 Considering that Medicare beneficiaries who 
qualify for coverage based on their age (65+ years of age) 
take a significant number of medications in comparison with 
other age groups, it is critical to focus on this population in 
order to identify and solve issues relating to nonadherence. 
Nonadherence can be classified as either unintentional or 
intentional. Unintentional nonadherence refers to a patient 
forgetting to take their medication(s), while intentional 
nonadherence refers to the patient weighing the pros and 
cons of taking a medication, and consciously deciding not to 
adhere to the medication regimen.14 Pharmacist consultation 
provides patients with information and strategies to optimize 
medication-related outcomes. Both types of nonadherence 
require distinct methods to address and correct the issue.14,15 
A  previous review of medication adherence from the phar-
macist perspective discussed mechanisms for assessing 
adherence and persistence, and strategies for improving adher-
ence.16 While many sophisticated and expensive methods of 
monitoring adherence are available, patient self-reporting 
remains the most common and least expensive means of 
assessing adherence. The factors impacting adherence that 
were discussed in the review included adverse effects of medi-
cation, perceived lack of effect, complexity of the regimen, 
asymptomatic conditions, physical limitations, psychiatric 
conditions, individual perceptions, family or cultural issues, 
and functional health literacy. The authors concluded that 
regardless of the various factors that contribute to nonad-
herence, effective communication between the pharmacist, 
patient, and other health care providers is critical. Use of 
open-ended questions in discussions, patient education on 
key consultation points, and provision of follow up was rec-
ommended. The authors further concluded that clarification 
of instructions, particularly for the elderly or patients with 
cognitive impairment, and scheduled follow up is essential. 
Optimal health care requires a team-based approach, and 
pharmacists are recognized as an integral part.17 Pharmacists 
are ideally situated to provide consultation to patients in the 
community setting. A comprehensive meta-analysis regarding 
the effects of pharmacist-provided patient care showed sta-
tistically significant beneficial outcomes in all three domains 
of therapeutic, safety, and humanistic outcomes, including 
medication adherence.18 Patients indicated that the top consul-
tation elements expected to be provided during their medica-
tion consultation included adverse effects, directions for use, 
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Medication adherence behaviors of Medicare beneficiaries
special instructions for unique prescriptions.19,20 However, 
deficiencies in patient consultation may translate to medica-
tion nonadherence. Studies conducted to examine this issue 
have identified several barriers that prevent patients from 
asking their pharmacists for a consultation. Patient barriers 
include fear of embarrassment, time constraints, and lack of 
initiative, education, or perceived need. In some cases, patients 
indicated that they trusted the physician to provide the needed 
information or that written information would be adequate. 
Lastly, the pharmacy may lack privacy or the pharmacist may 
be perceived as unapproachable.19–22 In order to decrease unin-
tended medication-related outcomes and increase medication 
adherence, further examination of pharmacists’ consultation 
from the patient’s perspective is critical. 
The objective of this study was to determine variables 
that impact self-reported medication adherence behaviors 
in an ambulatory Medicare population. Since nonadherence 
can be impacted by knowledge of the medication, factors that 
impact information provided during pharmacist consultations 
with this population were also examined.
Methods 
This study was conducted with the approval of the Institu-
tional Review Board of the University of the Pacific. Twelve 
community outreach events were conducted during the 2013 
MPD Open Enrollment Period in six central and northern 
California cities. Medication therapy management (MTM) 
was offered to all beneficiaries taking at least one medication. 
MTM was conducted by student pharmacists under the super-
vision of licensed pharmacists. During MTM, patients were 
asked to provide verbal informed consent and were invited 
to answer a series of survey questions asked by student phar-
macists. Participants were given the option of not answering 
each of the questions and were informed that they could stop 
answering questions at any time and still receive all services, 
without penalty. A standardized data collection tool was used 
to collect demographic information, social history, subsidy 
status, and medication and disease state information, and 
to document answers to survey questions. Each beneficiary 
was asked “Which of the following best describes how often 
you take your medications as directed”. Answer options 
included: “all of the time”; “most of the time”; “some of the 
time”; and “none of the time”. A beneficiary who responded 
with anything other than “all of the time”, was then asked 
“What is/are the main reason(s) that you do not take your 
medication as directed?” The respondent could select any (or 
all) option(s) that applied from the following, including: “I 
forget to take my medications”; “I do not get my medication 
refilled on time”; “I experience side effects”; “I do not know 
what the medication is for”; “I do not think I need it”; “I do 
not think it is helping me”; “I want to save some for later”; 
or “I cannot afford it”.
Next, an assessment of critical elements of pharmacist 
consultation was conducted. Beneficiaries were asked 
“Which of the following is typically discussed in a consulta-
tion with your pharmacist?” Beneficiaries answered “yes” 
or “no” to each element. The elements included: “What the 
medication is called and what it is used for”; “How and when 
you should take it and for how long”; “What you should do if 
you miss a dose”; “What the side effects are”; and “Whether 
it is safe to take with other medicines or vitamins”.
Descriptive statistics were reported for beneficiary demo-
graphic and clinical characteristics. Each demographic and 
clinical characteristic was analyzed to determine its effect 
on adherence. Chronic conditions were also evaluated to 
determine their association with self-reported adherence. Chi-
square and Fisher’s exact tests were used for each variable, to 
compare those who reported taking medication all of the time 
with those who reported taking medication less than all of the 
time. The Mann–Whitney test was used to evaluate the effects 
of self-reported adherence as a function of level of education, 
number of chronic medications, and number of chronic condi-
tions. Variables that could impact whether critical consultation 
elements were provided were also analyzed using inferential 
statistics. Chi-square and Fisher’s exact tests were used to 
examine the differences in what was typically discussed during 
a pharmacist consultation as a function of demographic and 
clinical characteristics. Alpha was set a priori to 0.05. Statis-
tics were performed via IBM SPSS Statistics for Windows, 
Version 20 (IBM Corp, Armonk, NY, USA).
Results
A total of 1,547 Medicare beneficiaries attended the outreach 
events; of those, 586 were provided MTM services. Of the 
beneficiaries who were provided MTM services, 575 (98%) 
completed the questions regarding medication adherence, 
and 532 (91%) completed the survey questions regarding 
pharmacist consultations. Demographic and clinical char-
acteristics are provided in Table 1. 
When asked about medication adherence, 406 (71%) 
reported taking their medication “all the time”, 143 (25%) 
reported taking their medication “most of the time”, and 
26 (4%) reported taking their medication “some of the time”. 
No individuals reported taking their medication “none of 
the time”. For the 169 (29%) beneficiaries who reported 
not taking medication all of the time, the reasons given 
are summarized in Table 2. Statistical analysis identified 
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Table 1 Demographics and clinical characteristics (n=586)
Sex, n (%) (N=566)  
Female 353 (62.4%)
Male 213 (37.6%)
Age, n (%) (N=550)  
65 years 36 (6.5%)
65–74 years 240 (43.6%)
75–84 years 169 (30.7%)
85 years 105 (19.1%)
Race/ethnicity, n (%) (N=564)  
White 352 (62.4%)
non-white 212 (37.6%)
Hispanic, n (%) (N=561)  
no 511 (91.1%)
Yes 50 (8.9%)
Preferred language, n (%) (N=570)  
english 407 (71.4%)
non-english 163 (28.6%)





Highest level of education completed, n (%) (N=557)  
grade 8 or less 58 (10.4%)
Some high school (grade 9–12) 45 (8.1%)
high school diploma or equivalent 94 (16.9%)
some college or associate degree 134 (24.1%)
Bachelor’s degree or higher 226 (40.5%)
Prescription drug coverage type, n (%) (N=543)  
Medicare Part D stand-alone prescription drug plan 383 (70.5%)
Medicare advantage prescription drug plan 81 (14.9%)
creditable coverage 46 (8.5%)
no coverage 33 (6.1%)
Prescription drug subsidy status, n (%) (N=436)  
non-subsidy recipients 285 (62.5%)
Subsidy recipients (ie, Medicaid or Low-Income Subsidy) 171 (37.5%)
Reported difficulty paying for medication, n (%) (N=456)
no 401 (92.0%)
Yes 35 (8.0%)










Medication-related problem identified during medication therapy management, n (%) (N=586)
no 225 (38.4%)
Yes (total) 361 (61.6%)
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Medication adherence behaviors of Medicare beneficiaries
 specific symptomatic medical conditions were associated 
with medication nonadherence. Additionally, beneficiaries 
for whom a medication-related problem was identified during 
the MTM session were found to be significantly less likely 
to be adherent with their medication(s). The factors that 
were statistically significantly associated with suboptimal 
medication adherence are shown in Table 3. 
Beneficiaries reported that critical elements were included 
in a typical pharmacist consultation between 46% and 71% of 
the time (Table 4). There was no statistically significant differ-
ence between sex, race/ethnicity, education level, prescription 
drug coverage type, number of prescription medications, or 
the presence of chronic conditions, such as hypertension, 
hyperlipidemia, or diabetes mellitus, in relation to pharmacist 
consultative elements. Subsidy recipients were less likely 
to report receiving elements of the pharmacist consultation, 
including medication name and indication (P=0.008) and 
consultation about side effects (P=0.006). Beneficiaries 
who spoke a language other than English were less likely to 
receive consultation regarding medication name and indication 
(P=0.014) or consultation about side effects (P=0.009). Further 
analysis revealed that beneficiaries who were subsidy recipi-
ents were significantly more likely to be non-English speak-
ers (P0.001). Certain health conditions, including benign 
prostatic hypertrophy, cancer, incontinence, and dementia, 
were associated with significantly more missing elements of 
the pharmacist consultation. In addition, our research identified 
that advancing age was associated with more missing elements 
for all critical components of the pharmacist consultation, 
some reaching statistical significance (Table 5).
Discussion
In our study population, level of education, sex, age, mari-
tal status, race/ethnicity, number of chronic medications or 
conditions, preferred language, or subsidy status were not 
significantly associated with self-reported medication adher-
ence. Our findings may differ from those of other studies in 
that within our population, less than 7% were younger than 
65 years, and 40% reported obtaining a bachelor’s degree or 
higher. Three factors were statistically associated with less 
than optimal adherence. These included some symptomatic 
conditions, issues related to paying for medication, and iden-
tifying medication-related problems during MTM. Our study 
identified an association between lower adherence rates in 
beneficiaries with symptomatic conditions, such as gastro-
esophageal reflux disease, coronary heart disease, asthma, 
allergic rhinitis, and anxiety. In our population, there was no 
association with depression or asymptomatic conditions, such 
as hyperlipidemia or hypertension and poor adherence, con-
trary to findings reported elsewhere.7 It is possible that some 
patients with symptomatic conditions may be inclined to take 
prescribed medications when experiencing symptoms, rather 
than routinely as prescribed. In order to ensure that patients 
are adherent for chronic but episodically symptomatic condi-
tions, pharmacists should include the reason the drug is being 
prescribed as part of the consultation. In our study population, 
70% of patients recalled that drug name and indication were 
included in the pharmacist consultation. Among, the partici-
pants in our study population who reported taking their medi-
cation less than all of the time, thinking that the medication 
was not needed was reported as one of the top three reasons. 
Another study has reported that the primary reason for inten-
tional nonadherence was a belief that the medication is not 
needed.23 Without a clear understanding of the purpose of the 
medication, patients may fail to adhere properly and eventually 
require emergent care or hospitalizations, to manage a poor 
medication outcome caused by intentional nonadherence. 
Cost of medication, even with the MPD prescription drug 
benefit, was a barrier to adherence in our study population. 
This finding is consistent with those reported by others.11,16 
In terms of overcoming cost barriers that lead to medication 
nonadherence, pharmacists or other patient advocates can 
provide assistance by ensuring that individuals are in the low-
est MPD cost plan, enrolling beneficiaries into pharmaceuti-
cal assistance programs, or assisting individuals to apply for 
Table 3 Factors associated with lower self-reported medication 
adherence
Variable P-valuea
Difficulty paying for medications 0.01
Medication-related problem identified during  
medication therapy management
0.008
Beneficiaries with gastroesophageal reflux disease 0.005
Beneficiaries with coronary heart disease 0.012
Beneficiaries with asthma 0.007
Beneficiaries with anxiety 0.01
Beneficiaries with allergic rhinitis 0.002
Note: aPearson’s chi-square.
Table 2 reported reasons for medication nonadherence (n=169)
Reason stated N (%)*
Forget to take 123 (72.8%)
Worrisome side effect 18 (10.7%)
Do not think it is needed 17 (10.1%)
Other 13 (7.7%)
Did not get refill in time 7 (4.1%)
cannot afford it 7 (4.1%)
Do not think it is helping 2 (1.2%)
Do not know what it is for 1 (0.6%)
Wanted to save some for later 1 (0.6%)
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the Low-Income Subsidy. Approximately 90% of Medicare 
beneficiaries could reduce their out-of-pocket prescription 
drug costs by annually reviewing their MPD plan.24 
The patients in our study who had a medication-related 
problem identified during the MTM process were statistically 
more likely to report less than optimal adherence. Experienc-
ing a worrisome side effect was the second most common 
reason stated for nonadherence in our population. Benefi-
ciaries in this study were offered MTM if they were taking 
one or more medications. The current inclusion criteria for 
MTM from the Centers for Medicare and Medicaid (CMS) 
allow MPD plan sponsors to require that patients take up to 
eight medications in order to meet the drug requirement for 
provision of MTM services.25 CMS data from 2012 reveal 
that 75% of MPD plan sponsors required a beneficiary to be 
taking seven or eight medications to qualify for MTM. The 
ability of pharmacists to provide MTM to a greater number 
of Medicare beneficiaries and therefore identify and resolve 
medication-related problems has the potential to improve 
adherence.26 A recent brief from the New England Health-
care Institute acknowledged the value of MTM to improve 
adherence and, ultimately, health care outcomes but recog-
nized the hesitance from stakeholders, particularly payers, 
to implement MTM on a broader scale.27
Advancing age was associated with lower reported rates 
of comprehensive consultation. Considering that most Medi-
care beneficiaries are over the age of 65 years, it is possible 
that our findings may reflect memory decline associated with 
advancing age or dementia and that beneficiaries did not 
recall elements covered in the consultation, or that  advancing 
age impacts what pharmacists discuss in a consultation. 
Forgetting to take medication was the most common reason 
for nonadherence reported by our study participants. One 
study reported that 70% of community dwelling seniors use 
a pillbox.28 Memory aids, medication reminders, and other 
adherence strategies should be offered, to minimize this 
form of unintentional nonadherence. Subsidy recipients and 
MDP beneficiaries who spoke a language other than English 
were less likely to receive elements of the pharmacist consul-
tation; however, further analysis revealed that beneficiaries 
who were subsidy recipients were significantly more likely to 
be non-English speakers, suggesting it may be the language 
barrier that produced the results.
Our research identified that although pharmacists gener-
ally include essential information that patients desire during 
a consultation, critical elements of medication consultation 
were omitted between 29% and 52% of the time. Pharmacist 
discomfort or lack of privacy may be contributing to the omis-
sion of consultation elements for specific conditions such as 
dementia, incontinence, and benign prostatic hypertrophy. 
Our research also found that patients with cancer were less 
likely to be counseled on how to take the drug and for how 
long. This may relate to a lack of knowledge by pharmacists 
about cancer therapy regimens.29
Considered to be the most accessible of the health care 
providers, pharmacists play an important role in the man-
agement of patients’ health, particularly as it relates to the 
medication regimen. In a published review of medication 
adherence from the pharmacist perspective, recommended 
strategies to improve adherence include ensuring  effective 
Table 5 Effect of age on information provided during pharmacist consultation: Percentage of Medicare beneficiaries in each age category 
who reported they received consultation elements
Element of consultation 65–74 years 75–84 years 85 years P-valuea
Drug name and indication 78% 68% 63% 0.038
how to take 76% 67% 52% 0.001
Missed dose 54% 46% 39% 0.055
side effects 63% 57% 46% 0.049
safe to take with other medicine 52% 46% 35% 0.080
Note: aMann–Whitney.
Table 4 Effects of chronic diseases on information provided during pharmacist consultation: percent of Medicare beneficiaries who 
reported they received consultation elements
Drug name and  
indication




Side effects Safe to take with 
other medicine 
Overall population 71% 68% 48% 58% 46%
Beneficiaries with cancer 69% 53%a 47% 49% 40%
Beneficiaries with incontinence 64% 55% 32%b 48% 30%c
Beneficiaries with benign prostatic hypertrophy 56%d 58% 44% 48% 40%
Beneficiaries with dementia 50%e 50% 20%f 37% 32% 
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Medication adherence behaviors of Medicare beneficiaries
communication between the pharmacist, patient, and 
 providers; use of nonjudgmental, open discussions; provision 
of clarifying instructions; and use of scheduled follow up, to 
provide additional support.16
In our population, mechanisms to enhance adherence could 
include medication education, medication reminders, elimina-
tion of cost barriers, and identification and resolution of side 
effects or other medication-related problems. Considering there 
are two types of nonadherence, intentional and  unintentional, 
mechanisms to overcome barriers must be tailored to the cause. 
By using an empathic, patient-centric communication style, 
clinicians may be more effective in identifying the presence 
of intentional and unintentional nonadherence and tailoring 
interventions to the needs of patients.15 
Limitations
There are several limitations to this study. The use of a survey 
to assess adherence relied on study participants’ self-reported 
behavior; objective measurements or validation of actual 
adherence rates were not conducted as our objective was to 
identify variables associated with nonadherence, rather than to 
determine adherence rates. Self-reported adherence data gath-
ered from patient interviews have historically overestimated 
adherence rates.16 Our survey was not a validated or com-
mercially available tool. While a validated adherence assess-
ment questionnaire could have been used to determine the 
adherence rate, additional questions would have to have been 
asked in order to identify other variables associated with non-
adherence. The Medication Adherence Questionnaire (MAQ) 
is a validated tool most commonly used because of its short 
length, ease of scoring, and previous validation in patients 
with a variety of chronic conditions.30,31 Our survey included 
variables that are assessed by the MAQ, such as forgetfulness, 
beliefs about the need for the  medication, and  presence of 
adverse effects, but we added items, including being unable 
to afford the medication. We did not assess adherence to 
individual medication but rather, to the medication regimen 
in general and thus are unable to make determinations about 
adherence variables for individual medications. 
Study participants were asked about a typical community 
pharmacist consultation. Again, this process relied on the 
individual’s ability to recall what was included in the con-
sultation, introducing potential recall bias. Direct observation 
of pharmacists’ consultations was not done. Nonetheless, the 
provision of patients’ perspectives on what they remember from 
a consultation is an important contribution to the literature. 
Our study surveyed Medicare beneficiaries from one 
geographic area that included northern and central California. 
Our population was predominantly white, and 40% reported 
attaining a college degree. Thus the applicability of our 
 findings to other Medicare populations may be limited. 
The study identified factors in a Medicare population that 
were statistically associated with reduced adherence as well as 
noncomprehensive consultation by pharmacists. An examination 
of the effectiveness of interventions to enhance adherence is 
needed. Comprehensive consultation by pharmacists for all ben-
eficiaries is desirable, but systematic supports, such as improved 
privacy, resources for consultations conducted in languages other 
than English, and strategies for effective targeting of uninten-
tional nonadherence related to forgetfulness are needed. 
Conclusion
This study adds to our understanding of self-reported adher-
ence behaviors in an ambulatory Medicare population. The 
30% of Medicare beneficiaries in our study population who 
reported not taking medication as prescribed all of the time pro-
vided reasons and thus, opportunities to enhance medication 
adherence. The top three reasons for nonadherence included 
forgetting to take medication, not taking medication due to 
a worrisome side effect, and belief that the medication was 
not needed. A statistical analysis identified factors that were 
associated with medication nonadherence, including patients 
with specific health conditions, patients who had a medication-
related problem identified during medication therapy manage-
ment, and those who reported difficulty paying for medication, 
even with the MPD benefit. While Medicare beneficiaries 
are generally more adherent to medication therapy than other 
groups, barriers must be identified and addressed. An effective, 
comprehensive pharmacist consultation could successfully 
address many of these  barriers and provide an opportunity 
to optimize drug therapy outcomes. Our study revealed that 
limited economic means (Medicaid or Low-Income Sub-
sidy recipients) and preferred language other than English 
were associated with lower rates of consultation discussion 
 regarding drug name and indication, and side effects. Further 
research is required to examine factors that lead to nonadher-
ence and to assess the effectiveness of interventions designed 
to improve patient well-being and avoid unnecessary health 
care spending. Next steps should include examination of 
the effectiveness and acceptability of different memory aids 
in the Medicare population, a prospective examination of 
which counseling elements are being covered in a pharmacist 
 consultation for this population, and lastly, examination of how 
often the consultation elements should be repeated to optimize 
retention and thus, support optimal adherence. 
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